J.P. Morgan Cuts Price Target on Acorda (ACOR) Stock Following Negative Ruling on Ampyra Patent

Did an iceberg just wallop into¬†Acorda (ACOR) stock? The drug maker’s shares are plunging at breakneck speed of almost 22% after the U.

J.P. Morgan Says Acorda Troubling Parkinson’s Trial Lessens Upside Potential

Acorda Therapeutics Inc (NASDAQ:ACOR) shareholders are spooked right now after the drug maker confirmed yesterday that enrollment in two long-term safety trials for …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts